GILEAD SCIENCES, INC. Other Noncash Income (Expense)
GILEAD SCIENCES, INC. (GILD) reported Other Noncash Income (Expense) of -$423.00 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:OtherNoncashIncomeExpense · last filed 2026-08-06
- GILEAD SCIENCES, INC. other noncash income (expense) for the quarter ending 2026-06-30 was -$240.00M.
- GILEAD SCIENCES, INC. other noncash income (expense) for the quarter ending 2026-03-31 was -$183.00M.
- GILEAD SCIENCES, INC. other noncash income (expense) for the quarter ending 2025-12-31 was -$267.00M.
- GILEAD SCIENCES, INC. other noncash income (expense) for the quarter ending 2025-09-30 was -$89.00M.
- GILEAD SCIENCES, INC. other noncash income (expense) for fiscal 2025 was -$480.00M.
- GILEAD SCIENCES, INC. other noncash income (expense) for fiscal 2024 was -$353.00M.
- GILEAD SCIENCES, INC. other noncash income (expense) for fiscal 2023 was -$826.00M.
- GILEAD SCIENCES, INC. other noncash income (expense) for fiscal 2022 was -$780.00M.
| Period end | Other Noncash Income (Expense) 3 month | Other Noncash Income (Expense) 3 month as first filed | Other Noncash Income (Expense) 6 month | Other Noncash Income (Expense) 6 month as first filed | Other Noncash Income (Expense) 9 month | Other Noncash Income (Expense) 9 month as first filed | Other Noncash Income (Expense) 12 month | Other Noncash Income (Expense) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$240.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$423.00M 10-Q · filed 2026-08-06 | -$690.00M derived: sum of 3 quarters · filed 2026-08-06 | -$779.00M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | -$183.00M 10-Q · filed 2026-05-07 | -$450.00M derived: sum of 2 quarters · filed 2026-05-07 | -$539.00M derived: sum of 3 quarters · filed 2026-05-07 | -$572.00M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | -$267.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | -$356.00M derived: sum of 2 quarters · filed 2026-02-24 | -$389.00M derived: sum of 3 quarters · filed 2026-08-06 | -$480.00M 10-K · filed 2026-02-24 | ||||
| 2025-09-30 | -$89.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | -$122.00M derived: sum of 2 quarters · filed 2026-08-06 | -$213.00M 10-Q · filed 2025-11-07 | -$272.00M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | -$33.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$124.00M 10-Q · filed 2026-08-06 | -$183.00M derived: sum of 3 quarters · filed 2026-08-06 | -$269.00M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | -$91.00M 10-Q · filed 2026-05-07 | -$150.00M derived: sum of 2 quarters · filed 2026-05-07 | -$236.00M derived: sum of 3 quarters · filed 2026-05-07 | -$325.00M derived: sum of 4 quarters · filed 2026-05-07 | ||||
| 2024-12-31 | -$59.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | -$145.00M derived: sum of 2 quarters · filed 2026-02-24 | -$234.00M derived: sum of 3 quarters · filed 2026-02-24 | -$353.00M 10-K · filed 2026-02-24 | ||||
| 2024-09-30 | -$86.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | -$175.00M derived: sum of 2 quarters · filed 2025-11-07 | -$294.00M 10-Q · filed 2025-11-07 | -$860.00M derived: sum of 4 quarters · filed 2026-02-24 | ||||
| 2024-06-30 | -$89.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$208.00M 10-Q · filed 2025-08-07 | -$774.00M derived: sum of 3 quarters · filed 2026-02-24 | -$829.00M derived: sum of 4 quarters · filed 2026-02-24 | ||||
| 2024-03-31 | -$119.00M 10-Q · filed 2025-05-07 | -$685.00M derived: sum of 2 quarters · filed 2026-02-24 | -$740.00M derived: sum of 3 quarters · filed 2026-02-24 | -$882.00M derived: sum of 4 quarters · filed 2026-02-24 | ||||
| 2023-12-31 | -$566.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | -$621.00M derived: sum of 2 quarters · filed 2026-02-24 | -$763.00M derived: sum of 3 quarters · filed 2026-02-24 | -$826.00M 10-K · filed 2026-02-24 | ||||
| 2023-09-30 | -$55.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$197.00M derived: sum of 2 quarters · filed 2024-11-12 | -$260.00M 10-Q · filed 2024-11-12 | -$494.00M derived: sum of 4 quarters · filed 2025-02-28 | ||||
| 2023-06-30 | -$142.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$205.00M 10-Q · filed 2024-08-08 | -$439.00M derived: sum of 3 quarters · filed 2025-02-28 | -$565.00M derived: sum of 4 quarters · filed 2025-02-28 | ||||
| 2023-03-31 | -$63.00M 10-Q · filed 2024-05-08 | -$297.00M derived: sum of 2 quarters · filed 2025-02-28 | -$423.00M derived: sum of 3 quarters · filed 2025-02-28 | -$661.00M derived: sum of 4 quarters · filed 2025-02-28 | ||||
| 2022-12-31 | -$234.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | -$360.00M derived: sum of 2 quarters · filed 2025-02-28 | -$598.00M derived: sum of 3 quarters · filed 2025-02-28 | -$780.00M 10-K · filed 2025-02-28 | ||||
| 2022-09-30 | -$126.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | -$364.00M derived: sum of 2 quarters · filed 2023-11-07 | -$546.00M 10-Q · filed 2023-11-07 | -$614.00M derived: sum of 4 quarters · filed 2024-02-23 | ||||
| 2022-06-30 | -$238.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | -$420.00M 10-Q · filed 2023-08-04 | -$488.00M derived: sum of 3 quarters · filed 2024-02-23 | -$467.00M derived: sum of 4 quarters · filed 2024-02-23 | ||||
| 2022-03-31 | -$182.00M 10-Q · filed 2023-05-03 | -$190.00M 10-Q · filed 2022-05-04 | -$250.00M derived: sum of 2 quarters · filed 2024-02-23 | -$229.00M derived: sum of 3 quarters · filed 2024-02-23 | -$557.00M derived: sum of 4 quarters · filed 2024-02-23 | |||
| 2021-12-31 | -$68.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-23 | -$47.00M derived: sum of 2 quarters · filed 2024-02-23 | -$375.00M derived: sum of 3 quarters · filed 2024-02-23 | -$576.00M 10-K · filed 2024-02-23 | -$1.22B 10-K · filed 2022-02-23 | |||
| 2021-09-30 | $21.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | -$307.00M derived: sum of 2 quarters · filed 2022-11-02 | -$508.00M 10-Q · filed 2022-11-02 | -$601.00M 10-Q · filed 2021-11-03 | -$476.00M derived: sum of 4 quarters · filed 2023-02-22 | |||
| 2021-06-30 | -$328.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | -$529.00M 10-Q · filed 2022-08-08 | -$576.00M 10-Q · filed 2021-08-05 | -$497.00M derived: sum of 3 quarters · filed 2023-02-22 | -$577.00M derived: sum of 4 quarters · filed 2023-02-22 | |||
| 2021-03-31 | -$201.00M 10-Q · filed 2022-05-04 | -$169.00M derived: sum of 2 quarters · filed 2023-02-22 | -$249.00M derived: sum of 3 quarters · filed 2023-02-22 | -$306.00M derived: sum of 4 quarters · filed 2023-02-22 | ||||
| 2020-12-31 | $32.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | -$48.00M derived: sum of 2 quarters · filed 2023-02-22 | -$105.00M derived: sum of 3 quarters · filed 2023-02-22 | -$178.00M 10-K · filed 2023-02-22 | -$250.00M 10-K · filed 2021-02-25 | |||
| 2020-09-30 | -$80.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | -$137.00M derived: sum of 2 quarters · filed 2021-11-03 | -$210.00M 10-Q · filed 2021-11-03 | -$290.00M derived: sum of 4 quarters · filed 2022-02-23 | ||||
| 2020-06-30 | -$57.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | -$130.00M 10-Q · filed 2021-08-05 | -$210.00M derived: sum of 3 quarters · filed 2022-02-23 | -$328.00M derived: sum of 4 quarters · filed 2022-02-23 | ||||
| 2020-03-31 | -$73.00M 10-Q · filed 2021-05-06 | -$59.00M 10-Q · filed 2020-05-06 | -$153.00M derived: sum of 2 quarters · filed 2022-02-23 | -$271.00M derived: sum of 3 quarters · filed 2022-02-23 | -$312.00M derived: sum of 4 quarters · filed 2022-02-23 | |||
| 2019-12-31 | -$80.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-23 | -$198.00M derived: sum of 2 quarters · filed 2022-02-23 | -$239.00M derived: sum of 3 quarters · filed 2022-02-23 | -$279.00M 10-K · filed 2022-02-23 | -$184.00M 10-K · filed 2020-02-25 | |||
| 2019-09-30 | -$118.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-04 | -$159.00M derived: sum of 2 quarters · filed 2020-11-04 | -$199.00M 10-Q · filed 2020-11-04 | -$159.00M 10-Q · filed 2019-11-05 | -$207.00M derived: sum of 4 quarters · filed 2021-02-25 | |||
| 2019-06-30 | -$41.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | -$81.00M 10-Q · filed 2020-08-06 | -$66.00M 10-Q · filed 2019-08-06 | -$89.00M derived: sum of 3 quarters · filed 2021-02-25 | -$122.00M derived: sum of 4 quarters · filed 2021-02-25 | |||
| 2019-03-31 | -$40.00M 10-Q · filed 2020-05-06 | $157.00M 10-Q · filed 2019-05-08 | -$48.00M derived: sum of 2 quarters · filed 2021-02-25 | -$81.00M derived: sum of 3 quarters · filed 2021-02-25 | -$162.00M derived: sum of 4 quarters · filed 2021-02-25 | |||
| 2018-12-31 | -$8.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | -$41.00M derived: sum of 2 quarters · filed 2021-02-25 | -$122.00M derived: sum of 3 quarters · filed 2021-02-25 | -$171.00M 10-K · filed 2021-02-25 | -$56.00M 10-K · filed 2019-02-26 | |||
| 2018-09-30 | -$33.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | -$114.00M derived: sum of 2 quarters · filed 2019-11-05 | -$163.00M 10-Q · filed 2019-11-05 | -$14.00M 10-Q · filed 2018-11-06 | -$240.00M derived: sum of 4 quarters · filed 2020-02-25 | |||
| 2018-06-30 | -$81.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | -$130.00M 10-Q · filed 2019-08-06 | -$149.00M 10-Q · filed 2018-08-06 | -$207.00M derived: sum of 3 quarters · filed 2020-02-25 | -$245.00M derived: sum of 4 quarters · filed 2020-02-25 | |||
| 2018-03-31 | -$49.00M 10-Q · filed 2019-05-08 | -$126.00M derived: sum of 2 quarters · filed 2020-02-25 | -$164.00M derived: sum of 3 quarters · filed 2020-02-25 | -$314.00M derived: sum of 4 quarters · filed 2020-02-25 | ||||
| 2017-12-31 | -$77.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | -$115.00M derived: sum of 2 quarters · filed 2020-02-25 | -$265.00M derived: sum of 3 quarters · filed 2020-02-25 | -$304.00M 10-K · filed 2020-02-25 | ||||
| 2017-09-30 | -$38.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | -$188.00M derived: sum of 2 quarters · filed 2018-11-06 | -$227.00M 10-Q · filed 2018-11-06 | -$247.00M derived: sum of 4 quarters · filed 2019-02-26 | ||||
| 2017-06-30 | -$150.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-06 | -$189.00M 10-Q · filed 2018-08-06 | -$209.00M derived: sum of 3 quarters · filed 2019-02-26 | -$233.00M derived: sum of 4 quarters · filed 2019-02-26 | ||||
| 2017-03-31 | -$39.00M 10-Q · filed 2018-05-09 | -$59.00M derived: sum of 2 quarters · filed 2019-02-26 | -$83.00M derived: sum of 3 quarters · filed 2019-02-26 | -$133.00M derived: sum of 4 quarters · filed 2019-02-26 | ||||
| 2016-12-31 | -$20.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | -$44.00M derived: sum of 2 quarters · filed 2019-02-26 | -$94.00M derived: sum of 3 quarters · filed 2019-02-26 | -$162.00M 10-K · filed 2019-02-26 | ||||
| 2016-09-30 | -$24.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | -$74.00M derived: sum of 2 quarters · filed 2017-11-07 | -$142.00M 10-Q · filed 2017-11-07 | $15.00M 10-Q · filed 2016-11-07 | -$670.00M derived: sum of 4 quarters · filed 2018-02-27 | |||
| 2016-06-30 | -$50.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-07 | -$118.00M 10-Q · filed 2017-08-07 | $7.00M 10-Q · filed 2016-08-05 | -$646.00M derived: sum of 3 quarters · filed 2018-02-27 | -$653.00M derived: sum of 4 quarters · filed 2018-02-27 | |||
| 2016-03-31 | -$68.00M 10-Q · filed 2017-05-10 | $19.00M 10-Q · filed 2016-05-06 | -$596.00M derived: sum of 2 quarters · filed 2018-02-27 | -$603.00M derived: sum of 3 quarters · filed 2018-02-27 | -$633.00M derived: sum of 4 quarters · filed 2018-02-27 | |||
| 2015-12-31 | -$528.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | -$535.00M derived: sum of 2 quarters · filed 2018-02-27 | -$565.00M derived: sum of 3 quarters · filed 2018-02-27 | -$562.00M 10-K · filed 2018-02-27 | ||||
| 2015-09-30 | -$7.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | -$37.00M derived: sum of 2 quarters · filed 2016-11-07 | -$34.00M 10-Q · filed 2016-11-07 | |||||
| 2015-06-30 | -$30.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-05 | -$27.00M 10-Q · filed 2016-08-05 | ||||||
| 2015-03-31 | $3.00M 10-Q · filed 2016-05-06 | $5.00M 10-Q · filed 2015-05-08 | ||||||
| 2014-09-30 | -$22.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-04 | -$48.00M derived: sum of 2 quarters · filed 2015-11-04 | -$51.00M 10-Q · filed 2015-11-04 | -$54.79M 10-Q · filed 2014-11-05 | ||||
| 2014-06-30 | -$26.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-05 | -$29.00M 10-Q · filed 2015-08-05 | -$21.41M 10-Q · filed 2014-08-04 | |||||
| 2014-03-31 | -$3.00M 10-Q · filed 2015-05-08 | -$3.12M 10-Q · filed 2014-05-07 | ||||||
| 2013-09-30 | -$18.46M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-05 | -$36.85M derived: sum of 2 quarters · filed 2014-11-05 | -$45.12M 10-Q · filed 2014-11-05 | -$45.27M derived: sum of 4 quarters · filed 2014-11-05 | ||||
| 2013-06-30 | -$18.39M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-04 | -$26.66M 10-Q · filed 2014-08-04 | -$26.81M derived: sum of 3 quarters · filed 2014-08-04 | -$23.71M derived: sum of 4 quarters · filed 2014-08-04 | ||||
| 2013-03-31 | -$8.26M 10-Q · filed 2014-05-07 | -$8.42M derived: sum of 2 quarters · filed 2014-05-07 | -$5.32M derived: sum of 3 quarters · filed 2014-05-07 | $7.38M derived: sum of 4 quarters · filed 2014-05-07 | ||||
| 2012-12-31 | -$159.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-27 | $2.94M derived: sum of 2 quarters · filed 2013-10-31 | $15.64M derived: sum of 3 quarters · filed 2013-10-31 | $1.88M 10-K · filed 2013-02-27 | ||||
| 2012-09-30 | $3.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-31 | $15.80M derived: sum of 2 quarters · filed 2013-10-31 | $2.04M 10-Q · filed 2013-10-31 | $1.26M derived: sum of 4 quarters · filed 2013-10-31 | ||||
| 2012-06-30 | $12.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-01 | -$1.06M 10-Q · filed 2013-08-01 | -$1.84M derived: sum of 3 quarters · filed 2013-08-01 | -$42.84M derived: sum of 4 quarters · filed 2013-08-01 | ||||
| 2012-03-31 | -$13.77M 10-Q · filed 2013-05-08 | -$14.54M derived: sum of 2 quarters · filed 2013-05-08 | -$55.55M derived: sum of 3 quarters · filed 2013-05-08 | -$68.95M derived: sum of 4 quarters · filed 2013-05-08 | ||||
| 2011-12-31 | -$772.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-27 | -$41.78M derived: sum of 2 quarters · filed 2013-02-27 | -$55.18M derived: sum of 3 quarters · filed 2013-02-27 | -$47.93M 10-K · filed 2013-02-27 | $47.93M 10-K · filed 2012-02-23 | |||
| 2011-09-30 | -$41.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-06 | -$54.41M derived: sum of 2 quarters · filed 2012-11-06 | -$47.16M 10-Q · filed 2012-11-06 | $47.16M 10-Q · filed 2011-11-04 | -$37.95M derived: sum of 4 quarters · filed 2013-02-27 | |||
| 2011-06-30 | -$13.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-01 | -$6.15M 10-Q · filed 2012-08-01 | $6.15M 10-Q · filed 2011-08-05 | $3.06M derived: sum of 3 quarters · filed 2013-02-27 | -$20.24M derived: sum of 4 quarters · filed 2013-02-27 | |||
| 2011-03-31 | $7.25M 10-Q · filed 2012-05-04 | $16.46M derived: sum of 2 quarters · filed 2013-02-27 | -$6.84M derived: sum of 3 quarters · filed 2013-02-27 | |||||
| 2010-12-31 | $9.21M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-27 | -$14.09M derived: sum of 2 quarters · filed 2013-02-27 | -$10.41M 10-K · filed 2013-02-27 | $10.41M 10-K · filed 2012-02-23 | ||||
| 2010-09-30 | -$23.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-04 | -$19.62M 10-Q · filed 2011-11-04 | ||||||
| 2010-06-30 | $3.68M 10-Q · filed 2011-08-05 | |||||||
| 2009-12-31 | $64.46M 10-K · filed 2012-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMGEN INC (AMGN) | United States | $219.567B | 22.39 |
| Moderna, Inc. (MRNA) | United States | $77.819B | -8.86 |
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| BIOGEN INC. (BIIB) | United States | $33.427B | 19.60 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |